Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.14 -0.01 (-0.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acurx Pharmaceuticals (ACXP) Other Accumulated Expenses (2024 - 2025)

Updated

Acurx Pharmaceuticals (ACXP) reported Other Accumulated Expenses of $4,357 for Q3 2025, down 1.8% from the prior quarter.

Analysis

Acurx Pharmaceuticals (ACXP) Other Accumulated Expenses (2024 - 2025) Analysis & Trends

At the end of FY2024, Acurx Pharmaceuticals posted Other Accumulated Expenses of $4,787.

  • Five-year quarterly Other Accumulated Expenses spans a low of $3,394 in Q1 2025 and a high of $4,787 in Q4 2024.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $4,436 (Q2 2025), $3,394 (Q1 2025) and $4,787 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn
10 Acurx Pharmaceuticals 4.86 Mn -28.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4,357.00
Jun 30, 2025 4,436.00
Mar 31, 2025 3,394.00
Dec 31, 2024 4,787.00
API Access

Acurx Pharmaceuticals Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACXP&period=max&api_key=YOUR_API_KEY